Chimeric antigen receptor--modified T cells: clinical translation in stem cell transplantation and beyond
- PMID: 23085599
- PMCID: PMC3654529
- DOI: 10.1016/j.bbmt.2012.10.021
Chimeric antigen receptor--modified T cells: clinical translation in stem cell transplantation and beyond
Figures
References
-
- Bacher U, Talano JA, Bishop MR. Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies. Biology of Blood and Marrow Transplantation. 2012;18(1 Suppl):S62–S73. - PubMed
-
- Eshhar Z, Waks T, Gross G, Schindler DG. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T cell receptors. Proceedings of the National Academy of Sciences of the United States of America. 1993;90(2):720–724. - PMC - PubMed
-
- Sadelain M, Riviere I, Brentjens R. Targeting tumours with genetically enhanced T lymphocytes. Nat Rev Cancer. 2003;3(1):35–45. - PubMed
-
- Song DG, Ye Q, Poussin M, Harms GM, Figini M, Powell DJ., Jr CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo. Blood. 2012;119(3):696–706. - PubMed
-
- Stephan MT, Ponomarev V, Brentjens RJ, et al. T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nature Medicine. 2007;13(12):1440–1449. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
